Deaths from hematologic malignancies have gone down slightly in recent years.
This data is freely available but anti-vaxxers would prefer to "ask questions" rather than seek answers.
“Plausible mechanisms” is the lowest level of medical evidence. I’m always happy to consider new data but the only things the Covid vaccine turbo cancer idea has in its corner are kooks and rare anecdotes.
I’m holding a hearing tomorrow at 2:30pm ET: “Plausible Mechanisms of COVID-19 Injections Causing Cancer and Attacks on Scientific Publications and Research.”
We’ll hear from 6 doctors and a cancer survivor:
- Angus Dalgleish, M.D.
- @weldeiry
- @SabinehazanMD,
- Saskia Mostert, M.D., PH.D.
- @DrAseemMalhotra
- @jrgralow
- Tamika Felder
Tune in on my X account and find more information at the link below⬇️
Check out our new podcast, The Digital Pulse. In the latest episode, host @BenMazer talks with algorithmic bias pioneer @oziadias.
https://t.co/wbJT64MgjL
No one has stopped you from asking questions. But you've repeatedly "asked questions" at anti-vax meetings and not provided any compelling evidence. You literally cited AI in some of your recent papers.
Epidemiologic data show that any theoretical risk must be miniscule.
Vaccines can save lives if safe and effective.
Those vaccines that are recommended by physicians after discussing individual risks and benefits with patients should be given with informed consent and covered by insurance.
But there have been some unexpected findings with pseudouridine-modified COVID mRNA vaccines tested for the first time in the global population at large.
These include unexpected persistence of the modified mRNA and spike protein in tissues, DNA fragment impurities and plasmid impurities with Process 2 production that were not tested in the early clinical trials that used Process 1 for COVID mRNA vaccine production.
Altered host immune responses with IgG4 class-switching, increased PD-L1 expression on cancer cells, neo-peptides resulting from ribosomal frame-shifting in pseudouridine-modified Spike mRNA, potential inhibition of tumor suppression mechanisms along with reported cases of cancer raise concern especially for individuals who may be at higher risk.
The unexpected observations warrant investigation including forensic evidence into impurities, biodistribution, mechanisms that affect the immune system and disease risk that includes cancer.
All known plausible mechanisms by which COVID mRNA vaccines might cause cancer as summarized in Kuperwasser and El-Deiry, 2026 are shown in the diagram below.
More research is needed on who is at greatest risk especially in the setting of 5, 6, and 7 modified-mRNA COVID vaccine injections.
Scientists should be allowed to ask questions and pursue the truth about disease risks and mechanisms without politics, attacks on their reputations or other career-altering consequences.
In my opinion, mRNA (and peptide) vaccines hold promise for cancer in a population with different risk benefit characteristics and should be further tested in clinical trials.
@KUPERWASSERLAB@Kevin_McKernan@DJSpeicher@RetsefL@SenRonJohnson@NIHDirector_Jay@NCIDirector@RandPaul@HHSGov@US_FDA@kharaguchi@MaryanneDemasi@RWMaloneMD@JanciToxDoc@danaparish@xazalbert@JesslovesMJK@efenigson
While the UK ran an RCT for blood-based cancer screening, the US simply started testing hundreds of thousands of patients.
In 2024, I asked: Are caner super-tests really such a good idea? Now the answer is no -- at least so far.
https://t.co/NJgfHu0xm9
Trial of multi-cancer blood test among 142,000 NHS patients fails to meet main aim
Results presented at oncology conference show Galleri test failed to reduce late-stage cancer diagnoses
https://t.co/kEnPYRgRWy
1/ the @NHS-Galleri trial is 1st RCT for molecular screening for early cancer detection. 142K participants; found ~1400 cancers overall (i.e. 1% ). No sig reduction in incidence rates of stage III/IV cancers. No change in rate @ prevalent vs incident rds.
NEW: Oura is partnering with Counsel to bring AI-enabled primary care into the Oura app
Users can ask medical questions, receive guidance, and connect with physicians using their wearable health data
This news comes just after Oura quietly filed for an IPO and launched Oura Ring 5
Are wearables the new patient-facing layer of healthcare AI?